Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics

RVNC POWR Grades

• Growth is the dimension where RVNC ranks best; there it ranks ahead of 63.17% of US stocks.
• The strongest trend for RVNC is in Growth, which has been heading up over the past 179 days.
• RVNC ranks lowest in Momentum; there it ranks in the 12th percentile.

RVNC Stock Summary

• RVNC's price/sales ratio is 18.65; that's higher than the P/S ratio of 92.42% of US stocks.
• As for revenue growth, note that RVNC's revenue has grown 407.65% over the past 12 months; that beats the revenue growth of 97.99% of US companies in our set.
• In terms of volatility of its share price, RVNC is more volatile than 89.3% of stocks we're observing.
• Stocks that are quantitatively similar to RVNC, based on their financial statements, market capitalization, and price volatility, are CLIR, AFIB, NCNO, FUV, and ACER.
• Visit RVNC's SEC page to see the company's official filings. To visit the company's web site, go to www.revance.com.

RVNC Valuation Summary

• In comparison to the median Healthcare stock, RVNC's EV/EBIT ratio is 124.23% lower, now standing at -7.1.
• Over the past 92 months, RVNC's price/sales ratio has gone down 693.6.
• Over the past 92 months, RVNC's price/sales ratio has gone down 693.6.

Below are key valuation metrics over time for RVNC.

RVNC Growth Metrics

Its 4 year net income to common stockholders growth rate is now at -138.65%.
• Its 2 year net income to common stockholders growth rate is now at -44.83%.
• Its 5 year price growth rate is now at 6.83%.

Over the past 34 months, RVNC's revenue has gone up $73,985,000.

The table below shows RVNC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	77.798	-221.538	-281.31
2021-09-30	62.981	-239.241	-296.521
2021-06-30	47.071	-241.76	-303.402
2021-03-31	28.566	-209.968	-291.795
2020-12-31	15.325	-178.502	-282.089
2020-09-30	4.281	-149.696	-249.106

RVNC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RVNC has a Quality Grade of D, ranking ahead of 5.83% of graded US stocks.
• RVNC's asset turnover comes in at 0.068 -- ranking 297th of 681 Pharmaceutical Products stocks.
• HGEN, ZSAN, and ARMP are the stocks whose asset turnover ratios are most correlated with RVNC.

The table below shows RVNC's key quality metrics over time.